SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
299After the conf call, I'd almost expected the stock to be up 20%. One of LenIan@SI-8/5/2003
298Stock down only 21% says it all.keokalani'nui-8/5/2003
297I just listened to the replay of this morning's conference call. Call is abIan@SI-8/5/2003
296Alexion Shares Tumble on Disappointing Study Results djones Dow Jones NewswirIan@SI-8/5/2003
295I think alxn is hoping whatever mortality benefit they are seeing will hold up akeokalani'nui-8/5/2003
294>>Am i interpreting this correctly that if A is the subclass of CABG withoIcebrg-8/5/2003
293is it common for these pr releases to be so cryptic- it would have been nice forMadharry-8/4/2003
292Alexion Pharmaceuticals Reports Preliminary Results Of Its Phase III PRIMO-CABG Icebrg-8/4/2003
291<i>Too busy playing piquet, no doubt.</i> Lounging around in rural nigel bates-8/3/2003
290<i>Doubt that it even piqued his interest.</i> Too busy playing piqBiomaven-7/27/2003
289>> Thankfully my retraction beat Nigel's correction. << Doubt tscaram(o)uche-7/22/2003
288peak = peek My excuse is I just spent 6 days in the mountains. Thankfully my rkeokalani'nui-7/22/2003
287AAT is deep space R&D, I think. They stopped talking about tpo agonist recekeokalani'nui-7/22/2003
286Alexion Antibody Technologies It seems they are (slowly, slowly) upgrading theiIcebrg-7/17/2003
285Old news. But not sure what the erratum says. Lancet. 2002 Sep 21;360(9337):92keokalani'nui-7/9/2003
284Rituximab Safe, Effective for Idiopathic Membranous Nephropathy Laurie Barclay,Icebrg-7/8/2003
283This Registration Statement is filed pursuant to General Instruction E to Form Skeokalani'nui-7/7/2003
282Alexion Pharmaceuticals Reports Third Quarter and Nine Month Results CHESHIRE,nigel bates-6/6/2003
281volume was a lot higher than normal and most of the biotechs have been doing welMadharry-6/5/2003
280Any thoughts on why ALXN did so well today?The Dodgy Ticker-6/5/2003
279I have added ALXN to my own little portfolio. My simple reasoning is that anti-iMadharry-5/15/2003
278Don't let's ask for the moon, We have the stars... (Apologies to Bette nigel bates-4/29/2003
277Wilder -- like i said, "very vulnerable". the moon i can take. i tom r. phillips-4/29/2003
276The registration trial of pexeli in cabg is to be announced at AHA in Nov. eculkeokalani'nui-4/29/2003
275<i>strapped to a rocket...</i> So long as there are no accidents on nigel bates-4/29/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News